Loading clinical trials...
Loading clinical trials...
The goal of this study is to determine whether indiplon, when administered with sertraline, improves insomnia symptoms and depressive symptoms in subjects with both insomnia and depression.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Neurocrine Biosciences
NCT05837104 · Bipolar I Disorder, Depression, Anxiety, and more
NCT06109363 · Insomnia, Sleep Disturbance
NCT06833788 · Postpartum Depression (PPD)
NCT06085950 · Treatment Resistant Depression
NCT07082218 · Concussion (Diagnosis), Concussion, Mild Traumatic Brain Injury, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions